Equine Partners America
Astaria Global's patented Alpha2EQ system is the first and only filtered plasma therapy process that concentrates and isolates the master protease inhibitor, Alpha-2-Macroglobulin (A2M). A2M binds to the proteases to stop tissue degradation. This is not just another blood product, all of the orthobiologic technology is in the molecule and its makes this offering the next generation of regenerative medicine.
While A2M is found readily in our blood, it is too large to enter the joint or disc space and is not able to flush out the high presence of proteases causing the degradation. With an Alpha2EQ Injection, patients can biologically "clean out" the joint and stop cartilage catabolism as well as prevent further degradation.
∑ Alpha-2-Macroglobulin (A2M) Highly concentrated
∑ Broad spectrum protease inhibitor that baits and traps all known factors causing cartilage catabolism and only system to centrifuge and filter plasma for isolated and concentrated A2M
∑ A2M has demonstrated upregulation of anabolic genes and down regulation of catabolic genes in joints
Benefits of the Alpla2EQ Injection
∑ Since it is totally autologous, it prevents any adverse side effects that are caused by drugs
∑ Offers the most potent and fastest acting anti-inflammatory on the market
∑ Since it offers 28-34 mLís in volume, it is extremely cost effective at $15.00/mL vs. any other blood product offering on the market
∑ Users have found the longevity of the injectionís effectiveness is a real benefit
Following is the link to the science behind Alpha2EQ and answers to some clinical questions from Dr. Kent Allen:Please call to arrange a demonstration or arrange for more information to be sent to you regarding Alpha2EQ.
(c) 2023 Equine Partners America, LLC